The Utility of Next-Generation Sequencing in the Treatment Decision-Making for Metastatic Non-Small-Cell Lung Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Maria Cristina,Orlov-Slavu ^[1] ; Ana Maria,Popa ^[1] ; Adrian,Tulin ^[2] ; Anca,Pantea Stoian ^[3] ; Catalina,Poiana ^[4] ; Cristian,Paleru ^[5] ; Valentin,Calu ^[6] ; Cornelia,Nitipir ^[7]

作者单位： Oncology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU. ^[1] General Surgery, Agrippa Ionescu Emergency Hospital, Bucharest, ROU. ^[2] Human Anatomy Department, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU. ^[3] Diabetes, Nutrition and Metabolic Diseases Department, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU. ^[4] Endocrinology, National Institute of Endocrinology C.I.Parhon, Bucharest, ROU. ^[5] Thoracic Surgery, Marius Nasta National Institute of Pneumology, Bucharest, ROU. ^[6] General Surgery, Elias Emergency Hospital, Bucharest, ROU. ^[7]

关键词 cancer genomic profiling next-generation sequencing oncology targeted therapy tumor agnostic treatment

DOI 10.7759/cureus.16919

PMID 34513491

发布时间 2023-09-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cureus

2021年13卷8期

e16919页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The Utility of Next-Generation Sequencing in the Treatment Decision-Making for Metastatic Non-Small-Cell Lung Cancer.

Cureus

相似文献

Cureus

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The Utility of Next-Generation Sequencing in the Treatment Decision-Making for Metastatic Non-Small-Cell Lung Cancer.

Cureus

相似文献

Cureus

相关期刊

检索历史清除